Synonyms- |
Introduction- |
Target |
Mechanism ANT activators [+1] |
Active Org. Rivus Pharmaceuticals, Inc.Startup |
Originator Org. Rivus Pharmaceuticals, Inc.Startup |
Active Indication |
Inactive Indication |
Drug Highest PhasePhase 2 |
First Approval Ctry. / Loc.- |
First Approval Date20 Jan 1800 |
Target |
Mechanism ANT activators |
Active Org. Rivus Pharmaceuticals, Inc.Startup |
Originator Org. Rivus Pharmaceuticals, Inc.Startup |
Active Indication |
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date20 Jan 1800 |
Target |
Mechanism ANT activators [+1] |
Active Org. Rivus Pharmaceuticals, Inc.Startup |
Originator Org. Rivus Pharmaceuticals, Inc.Startup |
Active Indication |
Inactive Indication- |
Drug Highest PhaseDiscovery |
First Approval Ctry. / Loc.- |
First Approval Date20 Jan 1800 |
Start Date24 Jul 2024 |
Sponsor / Collaborator Rivus Pharmaceuticals, Inc.Startup |
Start Date26 Mar 2024 |
Sponsor / Collaborator Rivus Pharmaceuticals, Inc.Startup |
Start Date17 Nov 2023 |
Sponsor / Collaborator Rivus Pharmaceuticals, Inc.Startup |